Purchase Order 75N90018P00542

<p>The NIH Clinical Center issued a purchase order to Qiagen, LLC on June 12, 2018 for $7,808.68 with firm fixed-price pricing and an ultimate completion date of June 20, 2018. Performance is at Bethesda, Maryland. The source does not specify what is being purchased.</p>

<p>The NIH Clinical Center awarded a purchase order to Qiagen, LLC valued at $12,770.00 on June 5, 2018, with an ultimate completion date of June 15, 2018. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC valued at $17,029.90 on August 24, 2018, with ultimate completion on August 24, 2019. The order is a firm fixed-price acquisition with no set-aside designation. Performance occurs in Valencia, California. The source does not specify the products or services procured under this order.</p>

<p>The NIH Clinical Center issued a purchase order to Qiagen, LLC on April 23, 2018, for $31,170.12 under firm fixed-price terms, with performance completion by April 30, 2019. The order carries no set-aside designation. Place of performance is Bethesda, Maryland.</p>

The NIH Clinical Center awarded a purchase order to Qiagen, LLC valued at $15,090 on July 28, 2017, with ultimate completion by August 27, 2018. Performance occurs in Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The purchase covers molecular diagnostics products and consumables, consistent with Qiagen's core offerings in DNA/RNA extraction kits, reagents, and related laboratory supplies supporting the Clinical Center's biomedical research and diagnostic...

<p>The NIH Clinical Center awarded a purchase order to Qiagen, LLC valued at $33,152.18 on May 16, 2019, with firm fixed pricing and a ceiling value of $33,152.18. Performance is located in Germantown, Maryland, with ultimate completion by May 31, 2020. The order was issued without a small business set-aside. No solicitation details regarding the specific items or services procured are provided in the source.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC for $15,500.00 with an award date of March 13, 2020 and ultimate completion date of March 12, 2021. Performance occurs in Bethesda, Maryland. The order is priced firm fixed price with no set-aside designation. The specific commodities or services procured are not detailed in the source.</p>

<p>The NIH Clinical Center awarded a purchase order to Qiagen, LLC valued at $7,735.00 on August 28, 2017, with final completion on September 28, 2017. The order is firm fixed price with no set-aside designation. Place of performance is Bethesda, Maryland.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC for $8,165.40 on November 22, 2017, with a completion date of December 1, 2017. Performance will occur in Bethesda, Maryland. The order is firm fixed price and carries no set-aside designation. The specific products or services procured are not detailed in the source material.</p>

<p>The National Institutes of Health Clinical Center issued a purchase order to Qiagen, LLC on August 4, 2017, for $12,830.65 under firm fixed price terms, with performance completion by August 10, 2017. Work is performed at Bethesda, Maryland. The order procures molecular diagnostics products and supplies, which are part of Qiagen's standard federal portfolio of DNA/RNA extraction kits, reagents, and laboratory consumables supporting biomedical research and clinical diagnostic operations.</p>